Continuous Glucose Monitoring in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes
End Stage Kidney Disease
About this trial
This is an interventional supportive care trial for End Stage Kidney Disease focused on measuring Burnt-out diabetes, Dialysis, End stage renal disease, Kidney failure
Eligibility Criteria
Inclusion Criteria: Dialysis treatment for more than 3 months HbA1c less than 6.5% at the first clinic visit Willing to wear a CGM for 10 days Exclusion Criteria: Have used insulin or any diabetes treatment during the last 3 months Be pregnant or plan to become pregnant during the study Known allergy to medical-grade adhesives Taking acetaminophen (more than 1 gram every six hours) or hydroxyurea (may interfere with sensor membrane) Current or anticipated use of stress steroid doses (prednisone </= 5 mg or its equivalent is allowed)
Sites / Locations
- Grady Memorial HospitalRecruiting
- Emory Dialysis at NorthsideRecruiting
- Emory Dialysis at GreenbriarRecruiting
- Emory Dialysis at CandlerRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
ESKD with Burnt-out Diabetes
ESKD without Diabetes
Participants with ESKD and burnt-out diabetes wearing a CGM for 10 days.
Non-diabetic participants with ESKD wearing a CGM for 10 days.